Q2 EPS Estimates for Legend Biotech Lifted by William Blair
Legend Biotech Co. (NASDAQ:LEGN – Free Report) – William Blair boosted their Q2 2025 earnings per share (EPS) estimates for Legend Biotech in a report issued on Tuesday, May 13th. William Blair analyst S. Corwin now forecasts that the company will post earnings of ($0.22) per share for the quarter, up from their prior estimate […]
